Skip to content

Board of Directors


Jeffrey G. Clark


With more than 40 years of medical device development experience, Jeff has spent most of it in successful start-ups . The first of which was Closure Medical Corporation where Jeff served as Vice President of R & D since the company was founded. He led the development of Dermabond topical skin adhesive which was the first topical skin adhesive to have been approved in the United States.  Closure Medical was acquired by Johnson & Johnson in 2005. He most recently retired from HyperBranch Medical Technology, Inc. where, since its inception, he served as the Chief Operating Officer leading development of its flagship product, Adherus AutoSpray Dural Sealant. For his final five years at HyperBranch, he served as Chief Executive Officer during which the product received FDA approval and was successfully commercialized. The company was acquired by Stryker Corporation in 2018.